Patents Assigned to Bioo Scientific Corporation
  • Publication number: 20140170649
    Abstract: Provided is a sensitive method to specifically detect nucleic acid sequences using a combination of DNA replication based signal amplification (e.g., PCR) and lateral flow analyte detection. The disclosed method uses a dual-labeled DNA probe complementary to a region of the target DNA sequence. Cleavage of the probe, caused by the presence of the amplified DNA target, is detected using lateral flow methods.
    Type: Application
    Filed: September 27, 2013
    Publication date: June 19, 2014
    Applicant: BIOO SCIENTIFIC CORPORATION
    Inventors: Joseph F. Krebs, Paul Morrison, Marianna Goldrick
  • Publication number: 20140128292
    Abstract: Described herein is a thermostable enzyme capable of efficient ligation of two oligomers at high temperature. The embodiments herein have led to the development of an optimized ligation step used in library preparation for sequencing reactions.
    Type: Application
    Filed: September 27, 2013
    Publication date: May 8, 2014
    Applicant: BIOO SCIENTIFIC CORPORATION
    Inventors: Masoud M. Toloue, Jason Dickson, Prachi Nakashe, Marianna Goldrick
  • Patent number: 8715676
    Abstract: Described herein are methods to express and purify recombinant type 1 ribosome inactivating proteins. Included are methods for using recombinant cucurmosin as a therapeutic to treat cancer and infectious diseases.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: May 6, 2014
    Assignee: Bioo Scientific Corporation
    Inventor: Mingang Chen
  • Publication number: 20140099656
    Abstract: Described herein is a rapid, semi-quantitative sampling device which may rapidly detect histamine in food, beverage and feed samples. The device uses an enzyme (impregnated in a sampling pad) to specifically convert histamine present in samples to a visual colorimetric signal. The color change of the pad is proportional to the amount of histamine present in the sample.
    Type: Application
    Filed: October 1, 2013
    Publication date: April 10, 2014
    Applicant: BIOO SCIENTIFIC CORPORATION
    Inventor: Joseph F. Krebs
  • Publication number: 20140046035
    Abstract: Anti-peptide antibodies (APAs) are extremely important tools for biomedical research. Many important techniques, such as immunoblots, ELISA immunoassays, immunocytochemistry, and protein microarrays are intrinsically linked to APA function and completely dependent on APA quality. Unfortunately, not all commercially-available APAs have good antigen binding characteristics; as a result, researchers are often unable to perform high quality protein analysis experiments. This disclosure describes a new method for the scalable production of polyclonal APAs using recombinant antigens. These recombinant peptide antigens have several advantages over traditional peptide antigens which improve the ease and speed of antibody production. The recombinant antigens can be scalably produced and purified much faster than traditional synthetic peptide-conjugates.
    Type: Application
    Filed: November 29, 2011
    Publication date: February 13, 2014
    Applicant: BIOO SCIENTIFIC CORPORATION
    Inventors: Joseph Krebs, Paul Morrison, Jun Wang
  • Patent number: 8637269
    Abstract: Melamine is a common industrial chemical contaminant which should be absent from food and feed supplies due to melamine's toxicity. Provided is a method to assess the presence of melamine in samples prepared from compositions. The method may include using a microbial enzyme called melamine deaminase which hydrolyzes melamine to ammeline and ammonia. The method may include assessing the presence of any ammonia produced from an enzymatic reaction between the sample and the enzyme.
    Type: Grant
    Filed: July 9, 2010
    Date of Patent: January 28, 2014
    Assignee: Bioo Scientific Corporation
    Inventor: Joseph Francis Krebs